BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8357170)

  • 1. VH gene family utilization of antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Verschuuren J; Bos N; van Breda Vriesman P; De Baets M
    Ann N Y Acad Sci; 1993 Jun; 681():285-7. PubMed ID: 8357170
    [No Abstract]   [Full Text] [Related]  

  • 2. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; Verschuuren JJ; Bos NA; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1993 Mar; 43(1-2):113-24. PubMed ID: 8458983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; De Baets MH
    Adv Neuroimmunol; 1994; 4(4):457-74. PubMed ID: 7719618
    [No Abstract]   [Full Text] [Related]  

  • 4. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire.
    Victor KD; Pascual V; Williams CL; Lennon VA; Capra JD
    Eur J Immunol; 1992 Sep; 22(9):2231-6. PubMed ID: 1516616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis and lymphoblastic lymphoma antiacetylcholine receptor antibody as a tumor marker--a case report.
    Mortimer JE; Kidd P
    Cancer Invest; 1989; 7(4):327-31. PubMed ID: 2686813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and functional characterization of human autoantibodies using combinatorial phage display libraries.
    Zeidel M; Rey E; Tami J; Fischbach M; Sanz I
    Ann N Y Acad Sci; 1995 Sep; 764():559-64. PubMed ID: 7486584
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models.
    Tournier-Lasserve E; Bach JF
    J Neuroimmunol; 1993 Sep; 47(2):103-14. PubMed ID: 8370764
    [No Abstract]   [Full Text] [Related]  

  • 8. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 9. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells.
    Kasturi KN; Mayer R; Bona CA; Scott VE; Sidman CL
    J Immunol; 1990 Oct; 145(7):2304-11. PubMed ID: 2118932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
    Newsom-Davis J; Harcourt G; Beeson D
    Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral pathogenesis of myasthenia gravis.
    Drachman DB; de Silva S; Ramsay D; Pestronk A
    Ann N Y Acad Sci; 1987; 505():90-105. PubMed ID: 2446560
    [No Abstract]   [Full Text] [Related]  

  • 13. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens.
    Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF
    Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease.
    Sundewall AC; Lefvert K
    Ann N Y Acad Sci; 1988; 540():525-7. PubMed ID: 3207283
    [No Abstract]   [Full Text] [Related]  

  • 15. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice.
    Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A
    Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis.
    Sims GP; Shiono H; Willcox N; Stott DI
    J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Kirvan CA; Zhu S; Richman DP; Agius MA
    Ann N Y Acad Sci; 1998 May; 841():466-8. PubMed ID: 9668275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.